Equities

Hester Biosciences Ltd

HESTERBIO:NSI

Hester Biosciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,431.95
  • Today's Change65.90 / 2.79%
  • Shares traded2.86k
  • 1 Year change+44.39%
  • Beta1.4011
Data delayed at least 15 minutes, as of Sep 20 2024 11:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments123127393
Total Receivables, Net1,0271,037697
Total Inventory823943823
Prepaid expenses131324
Other current assets, total16015610
Total current assets2,1462,2761,948
Property, plant & equipment, net4,0764,0503,170
Goodwill, net------
Intangibles, net392920
Long term investments299253212
Note receivable - long term2545210
Other long term assets303232
Total assets6,6236,7005,622
LIABILITIES
Accounts payable264300180
Accrued expenses116.815.26
Notes payable/short-term debt314589348
Current portion long-term debt/capital leases259248235
Other current liabilities, total210344200
Total current liabilities1,0581,487969
Total long term debt1,8711,9051,698
Total debt2,4442,7422,282
Deferred income tax747465
Minority interest1118874
Other liabilities, total592349215
Total liabilities3,7063,9023,022
SHAREHOLDERS EQUITY
Common stock858585
Additional paid-in capital175175175
Retained earnings (accumulated deficit)2,6262,5052,323
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total323217
Total equity2,9182,7972,600
Total liabilities & shareholders' equity6,6236,7005,622
Total common shares outstanding8.518.518.51
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.